| BIOGEN INC. DL -,0005 |
| USA |
| Gesundheit |
| US09062X1037 / 789617 |
| IDP (Frankfurt) / BIIB (NASDAQ) |
| FRA:IDP, ETR:IDP, IDP:GR, NASDAQ:BIIB |
| https://www.biogen.com/ |
|
Biogen Inc. is a globally recognized biotechnology..
>Volltext.. |
| 22045.05 Mio. EUR |
| 24271.71 Mio. EUR |
| 8280.87 Mio. EUR |
| 2771.17 Mio. EUR |
| 1374.69 Mio. EUR |
| 9.39 EUR |
| 5631.82 Mio. EUR |
| 3301.1 Mio. EUR |
| 2096.82 Mio. EUR |
| 1.2 |
| -0.37% |
| -5.5% |
| - |
| - |
| - |
| - |
| BIOGEN |
| 11.12.25 |
|